|1. Jennett B, Teasdale G. Management of head injuries. Philadelphia: FA Davies, 1981.|
|3. Alderson P, Roberts I. Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ 1997;314:1855-9.|
4. Bracken MB, Shepard MJ, Collins WF, et al. A randomised controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Eng J Med 1990;322:1405-11.
6. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604
7. Demopoulos HB, Flamm ES, Seligman ML. Further studies on free radical pathology in the major central nervous system disorders: effects of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can J Physiol Pharmacol 1982;60:1415-24.
8. Anderson DK, Saunders RD, Demediuk P. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Central Nervous System Trauma 1985;2:257-67.
12. Gaab MR, Trost HA, Alcantara A, et al. Ultrahigh dexamethasone in acute brain injury. Results from a prospective randomised double-blind multi-centre trial. Zentralblatt fur Neurochirurgie 1994;55:135-43.